InvestoGain Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

USCOM LIMITED(UCM)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of UCM: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Level 8, 210 George Street, Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001

Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)
Fax : Within Australia: 1300 653 459 Outside Australia: +61 2 9279 0664
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000UCM2
Address: Suite 2, Level 8 66-74 Clarence Street, Sydney NSW 2000
Tel:  (02) 9247 4144 Fax: (02) 9247 8157

Date first listed: 10/12/2003
Company Secretary: 
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Commercialisation of the USCOM Monitor, a device that provides an alternative to existing invasive and expensive methods of cardiac output measurement

News & Events

Expand this box to read and print

The company will hold its general meeting at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW at 3pm (Sydney time) on 7 November 2025.

08/10/2025

The company has reached an agreement to sell its businesses and assets to AXO Medtech VCC of Singapore, pending shareholder approval in November 2025. This decision comes after sustained financial losses and difficulties in securing funding in Australia. The sale involves Uscom's subsidiary, Uscom Sng Pte. Ltd, which is valued at $2.591 million and holds all of Uscom's intellectual property. Uscom will transfer existing liabilities, leading to approximately $200,000 in cash assets post-sale, and the agreement awaits regulatory approvals and standard transaction conditions.

30/09/2025

ASX has suspended Uscom Limited's securities from quotation due to breach of Listing Rule 12.2, based on the company's financial condition and auditor's report. The suspension will continue until ASX determines compliance with the rules and if securities can be reinstated to quotation.

29/09/2025

The suspension of trading in the securities of USCOM Ltd will be lifted immediately, following the release by UCM of an announcement regarding a clarification of a recent announcement of UCM's orders.

11/02/2020

The company releases a clarification to market in response to a request for further information and suspension from the ASX. Uscom is planning to increase manufacturing output by approximately 121% on 10 year average outputs to meet the anticipated demand for H2. Unit orders for the first five weeks of 2020 are up 124% compared to the first full two months of 2019 from 17 to 38 (unaudited), and prior to the Government announcement. Uscom will continue to update the market with material information as it is confirmed and will release its 4C as required.

11/02/2020

The securities of USCOM Ltd will be suspended from quotation immediately under Listing Rule 17.3, pending the release of an announcement regarding a clarification of a recent announcement of UCM's orders.

10/02/2020

The suspension of trading in the securities of Uscom Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding a capital raising and transaction. Security Code: UCM

20/07/2015

The company s pleased to announce the completion of a $1.55m Placement to professional and sophisticated investors (Placement). The company is also pleased to announce a Share Purchase Plan (SPP) to be underwritten up to $400k by Patersons Securities Limited (Patersons). The proceeds from the capital raise will be used to fund the acquisition of Thor Laboratories KFT (Thor), integration of Thor's operations into Uscom's existing operations, and for working capital.

20/07/2015

The company releases its July 2015 Investor Presentation.

20/07/2015

The securities of Uscom Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising and transaction. Security Code: UCM

17/07/2015

listed entity carried for record purposes only

01/07/2004

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    29/06/2021Rob Phillips165,579$0.166$27,453.00
    28/06/2021Rob Phillips644,627$0.159$102,293.00
    26/05/2021Xianhui Meng422,292$0.178$75,081.00
    25/05/2021Xianhui Meng1,000,000$0.145$144,643.00
    09/12/2020Brett Crowley200,000$0.186$37,274.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Rob PhillipsChairman, CEO23/12/1999
    Xianhui MengNon Exec Director16/12/2019
    Christian BerneckerNon Exec Director25/11/2011
    Brett CrowleyNon Exec Director, Company Secretary23/08/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.